A Temple News feature on medicinal cannabis research at the Lewis Katz School of Medicine at Temple University, includes comments from Sara Jane Ward, PhD, Assistant Professor of Neural Sciences in the Center for Substance Abuse Research, and Kelly A. Whelan, PhD, Assistant Professor of Cancer and Cellular Biology in the Fels Cancer Institute for Personalized Medicine.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH